These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35600796)

  • 1. Severe gastritis due to pembrolizumab treatment in a lung cancer patient.
    Hayama N; Ihara H; Honma Y; Itoigawa Y; Kaira K; Fujii M
    Respirol Case Rep; 2020 Oct; 8(7):e00636. PubMed ID: 35600796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
    Beck TN; Kudinov AE; Dulaimi E; Boumber Y
    BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
    Cassol CA; Owen D; Kendra K; Braga JR; Frankel WL; Arnold CA
    Histopathology; 2020 Aug; 77(2):240-249. PubMed ID: 32298485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of acute lymphocytic gastritis related to treatment with pembrolizumab for metastatic urothelial carcinoma.
    Fukiishi Y; Fukuhara H; Kurano Y; Shugimoto H; Yamashita E; Karasima T; Inoue K
    IJU Case Rep; 2023 Mar; 6(2):128-132. PubMed ID: 36874988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitor-Induced Hemorrhagic Gastritis.
    Mathialagan K; Tai CH; Sethi S; Thomas S; Loeser C
    ACG Case Rep J; 2023 Aug; 10(8):e01128. PubMed ID: 37583508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe immune checkpoint inhibitor-associated gastritis: A case series and literature review.
    Sugiyama Y; Tanabe H; Matsuya T; Kobayashi Y; Murakami Y; Sasaki T; Kunogi T; Takahashi K; Ando K; Ueno N; Kashima S; Moriichi K; Tanino M; Mizukami Y; Fujiya M; Okumura T
    Endosc Int Open; 2022 Jul; 10(7):E982-E989. PubMed ID: 35845030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Checkpoint Inhibitor-Induced Upper Gastrointestinal Tract Inflammation Shows Morphologic Similarities to, but Is Immunologically Distinct From, Helicobacter pylori Gastritis and Celiac Disease.
    Irshaid L; Robert ME; Zhang X
    Arch Pathol Lab Med; 2021 Feb; 145(2):191-200. PubMed ID: 33501492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping Hepatotoxicity and Colitis Associated with Immune Checkpoint Inhibitors.
    Malik A; Yousaf MN; Samiullah S; Tahan V; Mahdi A
    J Community Hosp Intern Med Perspect; 2023; 13(3):75-78. PubMed ID: 37877043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis.
    Grover S; Ruan AB; Srivoleti P; Giobbie-Hurder A; Braschi-Amirfarzan M; Srivastava A; Buchbinder EI; Ott PA; Kehl KL; Awad MM; Hodi FS; Rahma OE
    JCO Oncol Pract; 2020 Sep; 16(9):e933-e942. PubMed ID: 32401685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.
    Gao S; He Z; Zhu J; Liang D; Zhao W; Yang S; Jiang W; Qiu K; Yu X; Wu J
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1199-1205. PubMed ID: 35689298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Unusual Case of Gastritis in One Patient Receiving PD-1 Blocking Therapy: Coexisting Immune-Related Gastritis and Cytomegaloviral Infection.
    Lu J; Firpi-Morell RJ; Dang LH; Lai J; Liu X
    Gastroenterology Res; 2018 Oct; 11(5):383-387. PubMed ID: 30344812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitor colitis: the flip side of the wonder drugs.
    Assarzadegan N; Montgomery E; Anders RA
    Virchows Arch; 2018 Jan; 472(1):125-133. PubMed ID: 29143108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful therapy for autoimmune myocarditis with pembrolizumab treatment for nasopharyngeal carcinoma.
    Wang Q; Hu B
    Ann Transl Med; 2019 Jun; 7(11):247. PubMed ID: 31317017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
    Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
    Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autopsy case of immune-related severe colitis due to long-term use of nivolumab in a patient with non-small cell lung cancer.
    Fujikawa M; Tajiri T; Takemura M; Nakao K; Yamamoto S; Takeda N; Fukumitsu K; Fukuda S; Kamemitsu Y; Uemura T; Ohkubo H; Maeno K; Ito Y; Oguri T; Niimi A
    Respir Med Case Rep; 2022; 39():101720. PubMed ID: 35993006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitor-induced colitis: A comprehensive review.
    Som A; Mandaliya R; Alsaadi D; Farshidpour M; Charabaty A; Malhotra N; Mattar MC
    World J Clin Cases; 2019 Feb; 7(4):405-418. PubMed ID: 30842952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous adverse effects of the immune checkpoint inhibitors.
    Collins LK; Chapman MS; Carter JB; Samie FH
    Curr Probl Cancer; 2017; 41(2):125-128. PubMed ID: 28190531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
    Wang DY; Salem JE; Cohen JV; Chandra S; Menzer C; Ye F; Zhao S; Das S; Beckermann KE; Ha L; Rathmell WK; Ancell KK; Balko JM; Bowman C; Davis EJ; Chism DD; Horn L; Long GV; Carlino MS; Lebrun-Vignes B; Eroglu Z; Hassel JC; Menzies AM; Sosman JA; Sullivan RJ; Moslehi JJ; Johnson DB
    JAMA Oncol; 2018 Dec; 4(12):1721-1728. PubMed ID: 30242316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients.
    Song P; Zhang D; Cui X; Zhang L
    Thorac Cancer; 2020 Sep; 11(9):2406-2430. PubMed ID: 32643323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.